【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
06.1 Mode of Infection Transmission
06.2 Geographical Distribution
06.3 Screening
06.4 Treatment
06.4.1 WHO Guidelines
06.4.2 AASLD guidelines
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Key Marketed Drugs for Treatment of Chronic Hepatitis C
09. Market Segmentation by MOA
09.1 Virus-specific Agents
09.1.1 Polymerase Inhibitors
09.1.2 Protease Inhibitors
09.2 Non-specific Agents
09.2.1 IFN-based Drugs
09.2.2 Others
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.2.1 Roche
18.2.2 Merck
18.2.3 Johnson and Johnson
18.2.4 Vertex Pharmaceuticals
18.2.5 Gilead
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 F. Hoffmann La Roche
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2013
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Geographical Segmentation by Revenue 2013
19.1.6 Business Strategy
19.1.7 Recent Developments
19.1.8 SWOT Analysis
19.2 Gilead
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Geographical Segmentation by Revenue 2013
19.2.4 Recent Developments
19.2.5 SWOT Analysis
19.3 Johnson & Johnson
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Business Segmentation by Revenue 2012 and 2013
19.3.5 Geographical Segmentation by Revenue 2013
19.3.6 Business Strategy
19.3.7 Recent Developments
19.3.8 SWOT Analysis
19.4 Merck
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Sales by Geography
19.4.6 Business Strategy
19.4.7 Key Developments
19.4.8 SWOT Analysis
19.5 Vertex Pharmaceuticals
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2012 and 2013
19.5.5 Geographical Segmentation by Revenue 2013
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Progression of Hepatitis C
Exhibit 3: Risk Factors for Hepatitis C Transmission
Exhibit 4: Prevalence Rates of Hepatitis C Across Different Geographies
Exhibit 5: Prevalence of Hepatitis C Genotypes in Tropical Latin America
Exhibit 6: Key Prevalence Data of Hepatitis C in East Asia and Pacific
Exhibit 7: Prevalence of Hepatitis C Genotypes in East Asia
Exhibit 8: Prevalence of Hepatitis C Genotypes in High Income Asia Pacific
Exhibit 9: Prevalence of Hepatitis C Genotypes in Australasia
Exhibit 10: Key Prevalence Data of Hepatitis C in Europe
Exhibit 11: Prevalence of Hepatitis C Genotypes in Eastern Europe
Exhibit 12: Prevalence of Hepatitis C Genotypes in Western Europe
Exhibit 13: Prevalence of Hepatitis C Genotypes in Central Europe
Exhibit 14: Key Prevalence Data of Hepatitis C in Latin America and Caribbean
Exhibit 15: Prevalence of Hepatitis C Genotypes in Tropical Latin America
Exhibit 16: Prevalence of Hepatitis C Genotypes in Andean Latin America
Exhibit 17: Prevalence of Hepatitis C Genotypes in Central Latin America
Exhibit 18: Prevalence of Hepatitis C Genotypes in South Latin America
Exhibit 19: Key Prevalence Data of Hepatitis C in Middle East and North Africa
Exhibit 20: Prevalence of Hepatitis C Genotypes in North Africa/Middle East
Exhibit 21: Key Prevalence Data of Hepatitis C in North America
Exhibit 22: Prevalence of Hepatitis C Genotypes in High Income Countries in North America
Exhibit 23: Key Prevalence Data of Hepatitis C in South Asia
Exhibit 24: Prevalence of Hepatitis C Genotypes in South Asia
Exhibit 25: Key Prevalence Data of Hepatitis C in Sub-Saharan Africa
Exhibit 26: Prevalence of Hepatitis C Genotypes in Central Sub-Saharan Africa
Exhibit 27: Prevalence of Hepatitis C Genotypes in East Sub-Saharan Africa
Exhibit 28: Prevalence of Hepatitis C Genotypes in South Sub-Saharan Africa
Exhibit 29: Prevalence of Hepatitis C Genotypes in West Sub-Saharan Africa
Exhibit 30: Screening Tests for Hepatitis C Infection
Exhibit 31: Global Hepatitis C Market 2013-2018 (US$ billion)
Exhibit 32: Global Hepatitis C Market Segmentation by MOA
Exhibit 33: Global Hepatitis C Market Segmentation by MOA 2013
Exhibit 34: Global Hepatitis C Market by Geographical Segmentation 2013
Exhibit 35: Geographical Segmentation of Pegasys Revenue 2013
Exhibit 36: Roche: Pipeline Candidates for Hepatitis C
Exhibit 37: Victrelis’ Revenue 2011-2013 (US$ million)
Exhibit 38: Merck: Pipeline Candidates for Hepatitis C
Exhibit 39: Johnson & Johnson : Incivo’s Revenue 2011-2013 (US$ million)
Exhibit 40: Olysio’s Revenue 2014 (US$ million)
Exhibit 41: Vertex Pharmaceuticals: Incivek’s Revenue 2011-2013 (US$ million)
Exhibit 42: Vertex: Pipeline Candidates for Hepatitis C
Exhibit 43: Gilead: Pipeline Candidates for Hepatitis C
Exhibit 44: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 45: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 46: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals Division)
Exhibit 47: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics Division)
Exhibit 48: Gilead: Geographical Segmentation by Revenue 2013
Exhibit 49: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 50: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 51: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Exhibit 52: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 53: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 54: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 55: Vertex Pharmaceuticals: Business Segmentation by Revenue 2013
Exhibit 56: Vertex Pharmaceuticals: Business Segmentation by Revenue 2012 and 2013 (US$ million)
【レポート販売概要】
■ タイトル：世界のC型肝炎治療薬市場（2014-2018）■ 英文：Global Hepatitis C Market 2014-2018
■ 発行日：2014年9月3日
■ 調査会社：TechNavio
■ 商品コード：IRTNTR4050
■ 調査対象地域：グローバル
- VSaaS（映像監視クラウドサービス）の世界市場2017-2021About Video Surveillance as A ServiceVideo surveillance is the process of monitoring or observing the activities, behavior, or movements of an individual or a group to provide enhanced security. It is used by retail stores, government departments, hospitals, transportation and logistics companies, and law enforcement agencies to prevent criminal activities. Integration of the video surveillance so …
- 食品保存容器のアメリカ市場2017-2021About Food Storage Container Food storage container manufacturers in the US are increasing investments in R&D to offer the best designs and materials. They are also focusing on improving the quality of products, keeping in mind the environmental and sustainability concerns. End-users are also looking for diversification for the uses of food storage containers. For instance, many end-users such as …
- ポリブタジェン・ラバ(BR)の世界市場予測Polybutadiene rubbe 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about polybutadiene rubbe market in the all-in-one report issued in a logical and easily accessible format. In addition to the a …
- Victoria Oil & Gas plc：石油・ガスの開発・生産動向及びコスト分析– 2012Victoria Oil & Gas plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Victoria Oil & Gas plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 航空機検査装置の世界市場：油圧系統、電気系統、通気系統About Aviation Test Equipment Aviation test equipment find their application in the regular checks conducted for maintenance of hydraulic, electrical, and pneumatic systems in an aircraft. These controls are necessary for the aircraft to retain its airworthiness. These equipment are also essential during the assembly of a plane, during its aftermarket services, and to check for its proper function …
- 医療用布類の世界市場分析：原材料（不織布、編上、織物）、用途別（埋め込み可能な製品、非植込み型製品、ヘルスケア･衛生製品）、セグメント予測The global medical textiles market is expected to reach USD 20.23 billion by 2022, according to a new report by Grand View Research, Inc. The rise in the number of elderly population, ongoing technological advancements and increase in health consciousness are fueling the growth of global medical textiles market. Burgeoning health concerns necessitating the criticality of awareness for better healt …
- 消費者向けLBS（位置情報サービス）の世界市場：ナビゲーション、位置追跡、旅行、SNS、友だち・家族捜索、ゲーム、健康、気象情報サービス等About LBS LBS or location-based services are information services that use real-time geographical data from a smartphone or mobile device to provide security services, information, and entertainment. LBS applications are predominantly used by consumers, government organizations, and small and medium-scale industries. These are mainly used in healthcare, supply-chain, and retail outlets. They provi …
- 世界の航空・防衛産業における3Dプリンティング及び付加製造市場3D Printing & Additive Manufacturing in the Aerospace & Defence Market 2015-2025: – our new study reveals trends, R&D progress, and predicted revenues Where is the additive manufacturing for aerospace and defence market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report reveals to you the potential revenues streams to 2025, assessing data, trends, …
- 2014 Innovative Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Technologies, and Their Market ApplicationsThe report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.Contains 197 pages and 6 tables
- 医療レポート：Diabetic Nephropathy-疫学予測（～2022）EpiCast Report: Diabetic Nephropathy - Epidemiology Forecast to 2022 Summary With the increasing prevalence of diabetes around the world, diabetic nephropathy is the most common type of chronic kidney disease (KDOQI, 2007; Zimmet et al., 2001). When uncontrolled diabetes persists for 15 to 25 years, the blood vessels in the kidneys are damaged, resulting in abnormal amounts of proteins, including …
- 企業コンテンツ管理ソリューションの世界市場予測・分析（～2021）MarketsandMarkets forecasts the Enterprise Content Management market size to grow from USD 28.10 Billion in 2016 to USD 66.27 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 18.7%. Exponential data growth, increasing need to manage data in enterprises, and the need for regulatory content management to enhance the operations are the major driving factors for the growth of this market. T …
- リチウムイオン電池の世界市場2016-2020About Li-ion Batteries Li-ion batteries are rechargeable batteries in which the Li-ion acts as the cathode and the carbon acts as the anode. Li-ion batteries have a good electrochemical performance with low resistance. The advantage of using Li-ion batteries is that they increase the thermal stability, have higher current density, and a longer shelf life as compared with other batteries available …
- センサー付きベアリングの世界市場予測（～2023年）The sensor bearing market is projected to grow at a CAGR of 5.2% from 2018 to 2023 The sensor bearing market is projected to reach USD 6.5 billion by 2023 from USD 5.1 billion in 2018, at a CAGR of 5.2% between 2018 and 2023. The major factors driving the sensor bearing market are increasing demand for sensor bearings from end-use industries, such as automotive and transportation, and enforcement …
- Nonalcoholic Steatohepatitis (NASH)：市場分析及び予測（～2017）OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 Summary GlobalData has released its new report, “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017”. The NASH market is currently deserted and awaits its first NASH-specific therapy. With novel mechanism of action awaiting approval such as: Genfi …
- ACモータドライブの世界市場2015-2019About AC drive A drive is an adjustable speed device that regulates the speed and direction of motors; adjustment is done by varying the current flow through motors. Based on the type of current flow, a drive is classified into two: AC drive and DC drive. An AC drive is used to control AC electric motors, while a DC drive is used to control DC electric motors. AC drives are widely used in process …
